Can a high-risk case-finding approach identify all women with thyroid dysfunction during pregnancy? Commentary

Nature Clinical Practice Endocrinology and Metabolism

Volumn 3, Issue 3, 2007, Pages 216-217

  Stagnaro Green, Alex ^a,b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; LEVOTHYROXINE; RADIOACTIVE IODINE;

AGGLUTINATION TEST; AUTOIMMUNE DISEASE; CASE FINDING; CHEMOLUMINESCENCE; ETHNICITY; FAMILY HISTORY; HIGH RISK PREGNANCY; HUMAN; HYPOTHYROIDISM; NOTE; OUTCOME ASSESSMENT; PATIENT INFORMATION; PREGNANT WOMAN; PRIORITY JOURNAL; THYROID DISEASE; THYROID FUNCTION TEST; THYROID SURGERY; UNITED KINGDOM;

EID: 33847204329     PISSN: 17458366     EISSN: 17458374     Source Type: Journal    
DOI: 10.1038/ncpendmet0421     Document Type: Note

References (5)

1. Haddow JE et al. (1999) Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 341: 549-555
2. Negro R et al. (2006) Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab 91: 2587-2591
3. Lazarus JH and Premawardhana LD (2005) Screening for thyroid disease in pregnancy. J Clin Pathol 58: 449-452
4. National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network [http://www.bsc.gwu.edu/MFMU/projects/brieftrl.cgi] (accessed 15 December 2006)
5. Surks MI et al. (2004) Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 291: 228-238